Joris J.G. Van Den Heuvel
Papers
1
Total Citations
17
H-Index
1
About
Joris J.G. Van Den Heuvel is a leading researcher in pharmaceutical technology and patient safety, with a specialized focus on the automation of chemotherapy compounding. His work addresses a critical challenge in oncology: minimizing human error and occupational exposure during the preparation of hazardous drugs. Van Den Heuvel’s most-cited study, "Robotic compounding versus manual compounding of chemotherapy: Comparing dosing accuracy and precision" (2020, 17 citations), provides pivotal evidence that robotic systems can significantly enhance dosing accuracy and precision compared to manual methods. This contribution has direct implications for clinical practice, offering a safer, more reliable alternative for hospital pharmacies. Beyond this landmark paper, his research explores the intersection of robotics, quality control, and pharmaceutical workflow optimization. With his findings informing both regulatory standards and technological adoption, Van Den Heuvel’s work is instrumental in advancing the safety and efficacy of cancer treatment delivery. His impact is felt by pharmacists, engineers, and clinicians striving to reduce medication errors in high-stakes environments.
Research Focus
Key Achievements
Top Papers
- 1